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Abstract
Background: Audit and feedback to physicians is commonly used alone or as part of multifaceted interventions.
While it can play an important role in quality improvement, the optimal design of audit and feedback is unknown.
This study explores how feedback can be improved to increase acceptability and usability in primary care. The trial
seeks to determine whether a theory-informed worksheet appended to feedback reports can help family physicians
improve quality of care for their patients with diabetes and/or ischemic heart disease.
Methods: Two-arm cluster trial was conducted with participating primary care practices allocated using
minimization to simple feedback or enhanced feedback group. The simple feedback group receives performance
feedback reports every six months for two years regarding the proportion of their patients with diabetes and/or
ischemic heart disease who are meeting quality targets. The enhanced feedback group receives these same reports
as well as a theory-informed worksheet designed to facilitate goal setting and action plan development in
response to the feedback reports. Participants are family physicians from across Ontario who use electronic medical
records; data for rostered patients are used to produce the feedback reports and for analysis.
Outcomes: The primary disease outcomes are the blood pressure (BP), and low-density lipoprotein cholesterol
(LDL) levels. The primary process measure is a composite score indicating the number of recommended activities
(e.g., tests and prescriptions) conducted by the family physicians for their patients with diabetes and/or ischemic
heart disease within the appropriate timeframe. Secondary outcomes are the proportion of patients whose results
meet targets for glucose, LDL, and BP as well as the percent of patients receiving relevant prescriptions. A
qualitative process evaluation using semi-structured interviews will explore perceived barriers to behaviour change
in response to feedback reports and preferences with regard to feedback design.
Analysis: Intention-to-treat approach will be used to analyze the trial. Analysis will be performed on patient-level
variables using generalized estimating equation models to adjust for covariates and account for the clustered
nature of the data. The trial is powered to show small, but clinically important differences of 7 mmHG in systolic
BP and 0.32 mmol/L in LDL.
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Background
Patients with diabetes or ischemic heart disease (IHD)
are at elevated risk of cardiovascular events, especially if
they have a history of both conditions [1]. Research
findings regarding quality indicators in diabetes and
IHD suggest agreement and acceptance of guidelines
amongst Canadian family practitioners, who manage the
bulk of care for these patients [2]. Unfortunately, there
remains a large gap between ideal and actual care pro-
vided to such patients, making them a common focus
for translational research [3]. Diabetes and IHD are con-
sidered particularly good targets for quality improve-
ment strategies such as audit and feedback which can
increase adoption and adherence to guidelines [4,5].
Audit and feedback has been defined as a ‘summary of
performance in a specific area with or without recom-
mendations for action’ [6] and is felt to be effective
because it may overcome physicians’ limited ability to
accurately self-assess [7]. Thus, audit and feedback
focuses on addressing the gap between ideal and actual
care that is within the control of the health care provi-
der and is often the foundation of multifaceted quality
improvement interventions.
The Cochrane review of audit and feedback [8] con-
cluded that it is effective, but the authors noted great
variability in the design and the effectiveness of feedback
interventions. That meta-analysis included 118 trials, find-
ing a median increase in compliance with guidelines of 5%
for dichotomous outcomes (inter-quartile range 3% to
11%) and 16% for continuous outcomes (inter-quartile
range 5% to 37%), but great heterogeneity in both inter-
vention design and reporting limited conclusions regard-
ing how to best implement audit and feedback. Therefore,
the important question to ask at this point is not whether
feedback is effective, but how feedback can be most effec-
tive. Optimal design and delivery of feedback should more
consistently lead to improved results, but few studies have
tested different designs of feedback [9]. In an attempt to
further delineate how to most effectively design and deliver
feedback interventions, Hysong completed a re-analysis of
the Cochrane review [10], finding that feedback had greater
effectiveness with increasing frequency, with written rather
than verbal or graphical delivery, and with feedback that
included ‘correct solution information.’ Most recently,
Gardner et al. conducted a reanalysis of the Cochrane
review to test target-setting and action plans as effect-
modifiers of feedback [11], but very few studies explicitly
described their use of targets and/or action plans, making
their report inconclusive.
Using theory to design an enhanced feedback
intervention
Briefly, performance feedback may be understood to work
by directing attention toward a discrepancy between an
expected or desired state and reality [12]. When present,
this discrepancy may encourage the recipient to generate
increased effort toward the goal, especially if the next
steps or sub-goals are clear. Alternatively, the feedback
may be perceived as inaccurate and disregarded, or the
feedback may result in the recipient lowering their goal to
make it more achievable [13]. To be effective, the ideally
designed feedback would consistently lead to changes in
behaviour by the recipient through increased efforts to
reach appropriate goals.
There are both theoretical and empirical reasons to
believe that feedback will be more effective if the recipi-
ents set goals [14] and develop action plans [15].
According to Goal-Setting Theory [16], those who are
dissatisfied with their performance will develop a change
in behaviour if they are committed to the goal and if
they meet a threshold level of self-efficacy for that task.
Bandura explains that people are more likely to try to
accomplish a goal if they believe their efforts will be
successful [17].
Psychologists have repeatedly shown that detailed
plans regarding where/when/how behaviours will be
enacted increases the likelihood of task accomplishment
[18]. In the context of feedback and goals, these plans
may increase goal-directed behaviours by increasing
self-efficacy. Action plans can also facilitate success by
increasing goal-commitment to overcome barriers such
as distraction or fatigue; implementation plans in parti-
cular seem to increase goal-directed behaviours [19].
Implementation intentions are developed through if/
then statements, wherein the participant must connect a
situation (if) with a behavioural response (then). With
some effort (i.e., considering and writing down the
plan), the connection made between contextual cues
and an action plan can become automatic, thereby
increasing goal attainment without conscious intent.
There is some empirical evidence that intensive inter-
ventions that help participants set practice improvement
plans in response to feedback can improve outcomes
[20], possibly by increasing goal commitment and self-
efficacy. Recognizing that feedback alone is sometimes
not enough to change provider behaviours, further
improvements have been found by pairing feedback with
more intensive (and expensive) co-interventions, such as
educational outreach visits [21]. Although these inten-
sive interventions are rarely explicitly informed by the-
ory [22], they presumably work because they help
participants to take action to improve outcomes for
patients. The assumption is that healthcare providers
intend to provide consistently high quality of care, but
are uncertain how to change their behaviours to accom-
plish this feat. Therefore, an intervention aiming to
close this intention-behaviour-gap could be very effec-
tive. In this study, it is expected that the feedback
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reports will draw family physicians’ attention to a discre-
pancy between actual and ideal care – e.g., fewer patients
than expected are at target blood pressure (BP) – and
that a theoretically-informed worksheet can be developed
to facilitate goal-setting and action-plans to enhance the
likelihood that they will take action to close this gap (e.g.,
implement systems to monitor at-risk patients with BP
above target). See Figure 1 for an illustration of potential
role of goal-setting and action plans on effectiveness of
feedback.
Study objectives and hypotheses
For family physicians receiving performance feedback
reporting the percentage of their patients with diabetes
and/or IHD who are achieving quality targets, the addi-
tion of a theory-informed worksheet designed to facili-
tate goal setting and the development of action plans
will lead to changes in behaviour and improved out-
comes. A second hypothesis is that those physicians in
the intervention group who properly complete the work-
sheet will have the largest improvement in outcomes.
Finally, we aim to explore qualitatively the perceived
barriers to behaviour change in response to feedback
reports and the preferences of family physicians with
regard to feedback design.
Methods
Study design
This is a mixed methods study built around a pragmatic,
cluster-trial with two arms; one group will receive ‘sim-
ple’ feedback, while the other will receive ‘enhanced’
feedback. Allocation is at the practice level to reduce
risk of contamination and the intervention directed at
the physician level. In Ontario, family physicians do
work in groups, but this generally involves sharing
administrative resources, not patients. The usual
approach is for chronic conditions to be dealt with by
the personal physician, while acute issues may be dealt
with by the available physician. Therefore, we believe
that an intervention aimed at the physician rather than
the entire clinic is appropriate. The analysis will be at
the patient level, including both disease-level outcomes
of BP and low-density lipoprotein cholesterol (LDL) and
a composite score of process variables, as detailed in the
‘outcomes’ section.
The lack of a control group receiving no feedback at
all is both necessary (because participants expected
something in return for contributing data) and prag-
matic (because most quality improvement interventions
include some degree of feedback, making this the ‘usual
care’ comparator) [23]. In particular, the Ministry of
Health and Long-Term Care in Ontario (MOHLTC) is
providing feedback reports to all family physicians as
part of its diabetes strategy [24].
This study has received approval from the Research
Ethics Office at Sunnybrook Health Sciences Centre
(271-2006) and is registered with ClinicalTrials.gov
(NCT00996645).
Participants and data collection
Through the Electronic Medical Record Administrative
data Linked Database (EMRALD), family physicians
from all regions of Ontario who have been using Prac-
tice Solutions® Electronic Medical Records (EMRs) for at
least 12 months have signed a data-sharing agreement
with the Institute for Clinical Evaluative Sciences (ICES)
where EMRALD is held. ICES is a prescribed entity,
under the province of Ontario’s Personal Health Infor-
mation Protection Act, which allows for the collection
of individual level health information for use in planning
and managing the healthcare system.
At ICES, mechanisms to extract, securely transfer, and
de-identify the EMR data have been established [25]. For
patient visits, consultations, investigations, and treat-
ments, data in EMRALD compare well with (and often
out-perform) administrative databases [unpublished
data]. Furthermore, algorithms to identify patients in the
EMRALD database with diabetes (sensitivity 83.1%, spe-
cificity 98.2%) [26] and IHD (sensitivity 72.4%, specificity
99.6%) [27] have been validated. Since publishing those
papers, we have made further improvement to the dia-
betes algorithm (by considering the ‘problem list’ and
‘past medical history’ fields in addition to the lab tests
and prescriptions) resulting in a sensitivity of 90.9% and
specificity of 99.2%. The algorithm for identification of
the IHD algorithm has also been improved by continuing
to refine the search terms used to identify patients in the
‘problem-list’ and ‘past medical history’ fields. The algo-
rithms developed for EMRALD do not require any spe-
cial coding or data input by the participating physicians.
Family physicians were originally invited to participate
in EMRALD through convenience sampling of EMR
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Figure 1 Illustration of hypothesized role played by goal-
setting and action-plan worksheet to promote increased effort
to improve care.
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users. Presently, all participants work in multi-provider
clinics and nearly all have access to allied healthcare
providers. As a result, participants are not necessarily
representative of all Ontario family physicians or of all
primary care EMR users. However, this concern is par-
tially mitigated by the varied characteristics of physi-
cians in the sample (Table 1). As EMRALD continues to
recruit new family physicians, the diversity of the sample
is expected to grow. The number of participating physi-
cians and practices in EMRALD may grow by as much
as 50% during the first six months of this trial.
For the present study, all EMRALD participants were
sent consent forms and invitations to participate. Mini-
mal eligibility criteria are applied. Physicians with less
than one year of experience with EMR or with less than
100 rostered, active adult patients will be excluded,
because these ‘new’ physicians would not have adequate
data to assess some of the quality indicators. To be con-
sidered active, and to ensure there is a history with the
physician, patients must have at least one visit between
12 and 36 months prior to the data upload date. The
EMR data for all remaining physicians are assessed to
ensure completeness with respect to electronic capture
of lab tests and prescriptions. Finally, because ICES does
not permit reporting of cells smaller than five (to ensure
confidentiality), the data for the remaining physicians
are assessed to ensure that each has more than five
patients with diabetes and more than five with IHD.
Setting
The Ontario Health Insurance Program pays for doctor
visits and laboratory tests, but covers medications only
for the elderly or those on social assistance. Over one-
half of the primary care providers in Ontario have
eschewed the old model of fee-for-service and joined
primary care reform models where capitation plays a
large role in compensation for patient care. To earn the
capitation fees, physicians and patients must co-sign an
agreement that officially adds the patient to the physi-
cian’s roster; through this process, patients are encour-
aged to seek care primarily with their own provider or
clinic. Only data from ‘rostered’ patients are included in
the trial.
All the physician participants in this project roster
their patients and most also benefit from the newest pri-
mary care reform process that provides funds to hire
allied healthcare providers to work in the clinic.
Although less than half of Ontario family physicians use
EMR, Practice Solutions® EMR has 45% of the Ontario
EMR market [28].
Intervention
The intervention has been developed through an itera-
tive process. The materials for dissemination were
designed after a review of the literature and consultation
with experts from continuing medical education, health
psychology, and knowledge translation.
Participants in both arms of the trial will each receive
an information package by courier every six months for
two years with multiple components, including a one-
page cover letter, a one-page explanation of how the
patient information was identified from EMRALD, a
one-page handout reviewing generic clinical and quality
improvement strategies for patients with diabetes and/or
IHD (based in part on the chronic care model [29]), and
two separate feedback reports. The first report will
describe the percentage of the participating physician’s
patients with diabetes who are meeting evidence-based
Table 1 Characteristics of initial 14 clinics and 54 family physicians in the trial
Clinic Characteristics (N = 14) Physician Characteristics (N = 54)
Roster size, median (IQR) Sex, n (%)
Total patients
(total N = 46,864)
2,759 (1,915 to 4,250) Male 30 (55.6%)
IHD or diabetes
(total N = 4,593)
263 (219 to 505)
Years in Practice, n (%)
Location, n (%) Less than or equal to 10 17 (31.5%)
Rural 7 (50.0%) 11 to 20 12 (22.2%)
More than 20 25 (46.3%)
Physicians per clinic, n (%)
1 to 2 5 (35.7%) Years using EMR, n (%)
3 to 5 4 (28.6%) Less than 3 5 (9.3%)
6 to 11 5 (35.7%) 3 to 6 45 (83.3%)
More than 6 4 (7.4%)
N, n = number, IHD = ischemic heart disease, EMR = electronic medical record.
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quality targets. The second will present similar informa-
tion regarding their patients with IHD. The quality tar-
gets used were chosen to be consistent with those used
by concurrent quality improvement interventions in
Ontario (Quality Improvement and Innovation Partner-
ship) [30] and with current guidelines (see Outcomes
section below). The reports will present information
comparing the performance achieved by the participat-
ing physician to the average achieved by the top 10% of
participants for any given measure. This type of com-
parator is similar to the achievable benchmark of care
previously shown to improve the effectiveness of feed-
back reports [31]. See Additional File 1 for prototype
feedback reports.
Participants randomized to the enhanced feedback arm
will receive exactly the same materials as the simple feed-
back arm, plus a one-page worksheet. This theory-
informed worksheet is designed to facilitate participants
in setting specific but challenging goals and help partici-
pants develop action-plans through the creation of imple-
mentation intentions (see Additional File 2 for prototype
of worksheet). An evaluation to assess the theoretical
validity of the intervention will be reported separately.
Based on our review of the literature, the largest
effects from goal setting and action planning seem to
come from actually developing the plan (and linking it
to a specific context to carry it out). For this reason, we
chose not to provide participants with a list of possible
actions. The participants, not the investigators, decide
how to improve upon a care gap that they identify as
important. Important mediators of the success of imple-
mentation intentions seem to be participant adherence
to instructions to develop an appropriate plan, partici-
pant self-efficacy, and the inclusion of ‘coping plans’ to
help participants plan ahead for situations that could
interrupt goal-oriented behaviours [32,33]. These factors
will be addressed explicitly in this trial by: offering six
‘Main-Pro-C’ [34] continuing medical education credits
to encourage full completion of the worksheet and to
permit monitoring of plans by the investigators; allowing
participants to set their own goals for improvement; and
requiring participants to develop a coping plan in the
intervention worksheet. The format in this aspect of the
worksheet is similar to previous studies [33], although
to our knowledge the application of this type of inter-
vention to family physicians is novel.
The worksheet in this intervention is similar in con-
cept to commitment-to-change procedures that are
increasingly used in the continuing medical education
field, based on multiple theories related to adult learning
[35]. Rigorous evaluations of such procedures are few,
but one study indicated that commitment-to-change can
mediate the effect of an educational intervention for
prescriptions [36]. Although a signature has not been
proven to increase the effectiveness of the commitment-
to-change procedure [37], it is included in the work-
sheet because it offers an opportunity to explicitly use
the word ‘commitment;’ this is thought to be a neces-
sary feature for the procedure to successfully generate
behaviour change (see Additional File 2 for prototype of
worksheet) [38]. We tested the worksheet design and
all other intervention materials with a group of non-
participating family physicians and they found it easy to
use. Specifically, they reported that they found the
instructions clear and advised no changes to the design.
To our knowledge, the application of this type of work-
sheet as a means of ‘enhancing’ the effectiveness of
audit and feedback is novel.
Allocation and blinding
Given the small number of practices (clusters) involved
in EMRALD, simple randomization cannot be expected
to generate two similar arms for this trial. Instead, mini-
mization was used to achieve balance at baseline across
the three primary outcomes and the number of patients
in each cluster who have diabetes and/or IHD. Using
the baseline data for each cluster, these variables were
classified as high or low using the median value as the
cut-point. This was conducted with the free software,
‘MINIM’ [39]. Enrolment will continue for a maximum
of six months; new practices will be minimized using
their baseline data.
Although minimization has been criticised for increas-
ing the risk for selection bias [40], the benefits of
achieving balance at baseline through the use of minimi-
zation outweighs the minor risks involved (especially for
small trials) and therefore has been widely recom-
mended [41,42]. We believe that risk of selection bias is
low in this case because the recruitment of the first
fourteen practices (clusters) was completed prior to allo-
cation of the practices using the minimization software.
Furthermore, allocation of practices will remain con-
cealed; study IDs will be used to ensure that the audit
process and statistical analysis will be blinded with
regard to group assignment. A research coordinator
who is otherwise unaffiliated with the study will use a
master list with study IDs and participant names to pre-
pare the intervention materials. Participants will not be
told explicitly which arm they are in; those in the
enhanced feedback group will not be aware that the
worksheet is the essential aspect of the intervention.
Timeline
The first reports were sent out in August 2010. Every
six months, practices will send new data uploads to
ICES so that new feedback reports can be produced and
distributed. Final analysis will occur after an audit at
24 months. See Figure 2 for cluster-flow diagram.
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Analysis
Outcomes
There will be two disease primary outcomes and one
process primary outcome. The disease primary out-
comes will be the patients’ most recent LDL and systolic
BP values, if they have been tested within 24 or
12 months, respectively. Though these are actually risk
factors, they are the target of cardiovascular risk man-
agement, and are therefore appropriate given the brevity
of the trial.
The process primary outcome is a composite process
score indicating whether patients with diabetes and/or
IHD are receiving the recommended prescriptions and
tests within the appropriate timeframes. These evidence-
based quality indicators are concordant with guidelines
[43-48] and are comparable to composite scores used in
similar studies [47]. All patients with diabetes and/or
IHD will receive a composite process score with a maxi-
mum of 6. For patients with diabetes, a maximum score
of 6 would indicate testing of urinary microalbumin and
serum LDL within a year, measuring BP and glycosylated
haemoglobin within six months, and having active pre-
scriptions for a statin and an angiotensin-modifying
agent. For patients with IHD, a maximum score of 6
would indicate testing fasting blood glucose within two
years and LDL within one year, measuring BP within six
months, and having active prescriptions for aspirin, a sta-
tin, and an angiotensin-modifying agent. For patients
with both diabetes and IHD, the maximum raw score will
be 7 (based on the same indicators as diabetes but adding
aspirin), but this will then be multiplied by 6/7 to stan-
dardize to a maximum score of 6, as outlined in Table 2.
Secondary outcomes were chosen because they may be
the targets of action by recipients of the intervention.
Thus, the secondary outcomes include: the proportion of
patients whose results meet the targets recommended in
guidelines for glucose, LDL, and BP; and the prescriptions
rates for insulin, beta blockers, angiotensin-modifying
agents, aspirin, and statins.
Analysis
Descriptive statistics will be calculated for all variables of
interest. Continuous measures will be summarized using
means and standard deviations whereas categorical mea-
sures will be summarized using counts and percentages.
We hypothesize that the enhanced feedback interven-
tion will lead to greater improvements in quality of care
for patients with diabetes and/or IHD. The analysis to
test this hypothesis will be carried out using multilevel
hierarchical modeling (using the generalized estimating
equation approach) to control for the effects of cluster-
ing as well as adjusting for multiple covariates, including
the variables used in the minimization (baseline values
for BP, LDL, the composite process score, and the num-
ber of patients with diabetes and/or IHD). Analysis will
be performed on an intention-to-treat basis. No interim
analyses are planned. Prior to analysis, other covariates
will be assessed for the presence of multicollinearity;
when the tolerance statistic value < 0.4 only one mem-
ber of a correlated set will be retained for the model.
Primary analyses will be conducted on patient level vari-
ables, combining patients with diabetes and/or IHD.
Sub-group analyses will be performed on patients with
only IHD, only diabetes, or both, to assess the same out-
come variables.
The efficacy of the worksheet intervention will be
assessed as a planned secondary analysis in two ways.
First, we will test whether full completion of the worksheet
resulted in improved outcomes. Full completion of the
Figure 2 Trial Design and Cluster-Patient Flow.
Table 2 Composite process score to be calculated for
each patient as primary process outcome; the score is
calculated differently for patients with diabetes, ischemic
heart disease, or both.
Quality indicator
(for each patient
receives a score)
Diabetes
(max
score = 6)
IHD (max
score = 6)
Both Diabetes + IHD
(multiply by 6/7
for max score = 6)
BP test in 6M X X X
A1C test in 6M X X
FBG test in 24M X
LDL test in 12M X X X
ACR test in 12M X X
Rx ASA X X
Rx Statin X X X
Rx ACE/ARB X X X
IHD = ischemic heart disease, BP = blood pressure, A1C = glycolated
haemoglobin, FBG = fasting blood glucose, LDL = low density lipoprotein
cholesterol, ACR = urinary albumin-to-creatinine ratio, ASA = aspirin, ACE/ARB =
angiotensin-modifying agent.
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worksheet will be evaluated according to whether they
declared specific and measurable goals, completed all sec-
tions of the action plan, and confirmed their commitment
with their signature. Second, we will examine if physicians
achieved greater improvements in the specific clinical
topics that they chose to target using the worksheet.
All analyses will be carried out using the SAS Version
9.2 statistical program (SAS Institute, Cary, NC, USA).
Sample size
Based on pilot data, systolic BP is expected have a stan-
dard deviation of 20 mmHg. A clinically important dif-
ference in systolic BP is estimated to be 7 mmHg; this is
a difference often seen with initiation of treatment and
is associated with reduction in cardiovascular risk [49].
To have 80% power to find a difference in systolic BP of
7 mmHg using a two-sided unpaired t-test with a =
0.05 would require 258 total patients. To account for
clustering, this sample size must be multiplied by a var-
iance inflation factor (VIF) = [1 + (n - 1) × ICC], where
n is the mean cluster sample size and ICC is the intra-
class correlation coefficient, a measure of the degree of
correlation within clusters [50]. From baseline data, the
mean cluster size (number of patients with diabetes
and/or IHD in each practice) is approximately 328.
Using a presumed ICC of 0.05 (based on ICCs seen in
the literature[51]), the VIF equals 17.4. Thus, 4,489
patients with diabetes and/or IHD are required to find a
difference of 7 mmHg in BP, which equates to 13.7
clusters.
For LDL values, pilot data show a standard deviation
of 0.90. Therefore, using the same calculations, the trial
will have power to show an absolute difference in LDL
of 0.32 mmol/L; this difference has been shown to be
associated with reduction in cardiovascular risk [52].
This type of small improvement in the management of
these very common chronic diseases could translate into
a large impact on the population scale.
Based on pilot data, the standard deviation for the
composite process primary outcome is expected to be
1.61. For this outcome, pilot data were also used to find
that the ICC was 0.0059, but to be conservative this can
be rounded up to 0.01, giving a VIF of 4.28. Therefore,
to show an absolute difference in the final composite
process score of 0.3 (effect size 0.19), a sample size of
3,878 patients would be needed, which equates to 11.82
clusters.
Most of the power in cluster-trials comes from the
number of clusters, rather than the number of patients.
Therefore, dropout of a few participating physicians (or
many of their patients) would only minimally decrease
power. We do not expect dropout of entire clinics; clinic
managers are committed to this project and have facili-
tated the recruitment of individual physicians at each
clinic. However, even with a loss of two of the fourteen
clinics, the same calculations indicate that we would
have 80% power to find differences of 8 mmHG BP or
0.36 mmol/L LDL.
Qualitative analysis and process evaluation
Previous qualitative studies have isolated timeliness, cus-
tomizability, and a non-punitive tone as key criteria for
‘actionable’ feedback [53]. Evidence from the organiza-
tional literature suggests that the recipient must be
satisfied with the feedback for it to be accepted and
acted upon [54]. Unfortunately, the literature has not
provided clear direction regarding how to design feed-
back interventions targeted at family physicians to
accomplish this goal.
One previous study has assessed eight Ontarian physi-
cians’ reactions to a 20-minute one-on-one performance
assessment presentation based on chart audits and
patient questionnaires, and found that physicians wel-
comed it [55]. Even though the data were garnered
directly from charts, the participants expressed concerns
about government involvement in the performance
improvement process. Another study revealed a general
scepticism amongst physicians regarding quality
improvement interventions based on secondary data-
bases [56]. Nevertheless, the MOHLTC, is now using
administrative data to send all family physicians ‘Dia-
betes Testing Reports’ regarding their patients with dia-
betes [57]. These reports from the government will
provide far less data to the physicians (and nothing
regarding patients with IHD) compared to the interven-
tion described in this protocol. This context provides an
opportunity to work with physicians receiving two types
of diabetes feedback to explore the barriers and facilita-
tors to Ontario family physicians’ acceptance and utiliza-
tion of performance feedback, and to examine the
perceived actionability of various approaches to the
design and delivery of feedback. While the ongoing gov-
ernment feedback will likely enrich the qualitative com-
ponent of the study, we do not believe that it will
impact the inferences made from the trial. All partici-
pants will receive the government feedback, but the gov-
ernment feedback does not explicitly encourage goal
setting or action plans.
Semi-structured, individual interviews will be con-
ducted using an interview guide, developed based on a
review of the literature and consideration of the twelve
domains described by Michie et al. to explain behaviour
change in response to an intervention [58]. We will use
‘stratified purposeful sampling’ [59]; we will select parti-
cipants with those features believed to be relevant, not
with the goal of probabilistic representativeness, but for
informational representativeness. For instance, guideline
adherence and quality of care may be inversely related
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to years in practice [60] and physician gender [61], so
variety will be sought in these factors. Additionally, the
participants will be chosen to represent varying levels of
baseline performance, because this was found to be an
important predictor in the Cochrane review. It is
expected that saturation may be accomplished with
approximately 12 interviews [62]. The sample will be
weighted with about two-thirds of participants having
received the enhanced feedback. To account for time
away from patient care, an honorarium will be offered
for participation.
Interviews will be recorded and a transcription service
used to produce verbatim electronic transcripts. These
will be stored with encryption software on a password-
protected computer drive. Identifying factors will be
omitted. NVivo™ software will be used to assist with the
data analysis. The framework analysis approach, as
described Ritchie and Spencer [63] (and more succinctly
by Pope et al.[64]) aims to accurately reflect the original
accounts of the participants through the use of inductive
techniques, yet start out deductively with preset goals.
As such, it represents an ideal foundation for analyzing
qualitative data within a pragmatic, mixed methods
study such as this one. For example, it has been success-
fully used in the past as part of a mixed method study
investigating barriers and facilitators to guideline uptake
in the ICU [65].
The identification of themes will be tracked along with
dates of interpretations to provide an audit trail docu-
menting the analysis. This is one way that trustworthi-
ness in the results can be increased [66]. Next, an index
of themes will be developed by combining a priori
objectives and issues identified in the literature with
those raised by the participants and recognized through
the readings. This process will occur after seven inter-
views have been completed and will be repeated in part
by a second researcher (JB). It is thought that multiple
coding provides a system of check and balances to
ensure that all possible themes are given consideration
[67]. Disagreements will be settled through consensus
and this process may lead to changes in the interview
guide. At this point, disconfirming evidence to ensure
saturation of themes will be sought from further partici-
pants through the use of snowball sampling (by asking
participants to suggest colleagues that may have unique
perspectives on feedback). In this way, elements of mul-
tiple coding and the constant comparative method will
be incorporated. Therefore, the qualitative protocol will
meet the criteria described by Kuper for judging qualita-
tive research [68].
Discussion
With the use of audit and feedback interventions likely
to increase over time, there is a need to understand how
their design effects the behaviour of primary care provi-
ders. This project will play a role in learning how to
generate feedback reports that are useful for family phy-
sicians. Even if the trial is negative, the qualitative pro-
cess evaluation will provide useful information and
generate new study questions. Future studies may then
compare the cost-effectiveness of using interventions
similar to the one described in this trial against more
intensive interventions such as academic detailing or
practice facilitators.
There are also some important limitations that war-
rant discussion. One concern regarding generalizability
is that it is possible that there will be a specific inter-
action between the worksheet intervention and the
feedback such that adding the worksheet to other
designs/types of feedback or other interventions may
not work as well. It is also important to note that par-
ticipants in EMRALD are a convenience sample of
Ontario family physicians using Practice Solutions®.
Therefore, findings from this group will not be strictly
generalizable to other providers who use different
EMR systems, or to those not using EMR at all. In
addition, many of the clinics are involved in other
quality improvement interventions. Thus, these clinics
may be more innovative and may also be achieving a
higher level of evidence-based care than most other
primary care providers.
Perceived data accuracy has been identified as an
essential feature for acceptance of feedback reports [69],
and previous studies have shown that data quality from
EMRs are uncertain [70]. While we have validated algo-
rithms for identifying patients who have diabetes and/or
IHD in this database, the automated chart audits that
are the basis for both the intervention and the outcome
assessment may occasionally have errors. However,
there is no reason to believe that any such errors occur-
ring in the data abstraction process represent a risk for
bias; any problems with the algorithm would be equally
likely to occur in either arm of the trial.
This is a pragmatic trial that is powered to find small
(but important) effects of a feedback intervention based
on the addition of a theoretically-informed worksheet.
While a longer, larger trial would be ideal to assess true
cardiovascular endpoints, the size and timeframe of this
trial have been designed to ensure feasibility. Psychologi-
cal theory applicable to feedback interventions indicates
that the worksheet intervention tested in this trial
should help family physicians to close the gap between
their intended and actual behaviours with respect to the
care they provide for their patients. If the intervention
works in this sample, it could be tested more broadly; if
it is not effective, it may be necessary to try more inten-
sive approaches to facilitate providers to achieve their
quality improvement targets.
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Additional material
Additional file 1: Feedback Intervention. Prototype of feedback report
that all participants will receive
Additional file 2: Goal-setting and Action-plan Worksheet for
Enhanced Feedback Intervention. Prototype of the intervention that
will be tested in the trial
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